2,5-Dioxopyrrolidin-1-yl 3-(2-(prop-2-yn-1-yloxy)ethoxy)propanoate, 96+%, 100mg

(S)-1-(tert-Butoxycarbonyl)-3-hydroxypiperidine>98.0%(GC)5g

(1H-INDAZOL-4-YL)METHANAMINE, 95%, 250mg

(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)methanamine, 97%, 1g

(1S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol, tech, 25g

4-amino-N-(2,6-dimethylphenyl)benzamide, 95.0%, 5g

3-(4-BROMOPHENYL)-3-(TRIFLUOROMETHYL)-3H-DIAZIRINE, 95%, 250mg

(S)-1-(2-Fluoro-4-methoxyphenyl)ethanamine hydrochloride, 95.0%, 1g

tert-Butyl 3-(2-oxopyrrolidin-3-yl)azetidine-1-carboxylate, 97%, 1g

1-[4-(Trifluoromethyl)pyrimid-2-yl]homopiperazine, 97.0%, 1g

2-(2-Methylamino-ethyl)-isoindole-1,3-dione, 95.0%, 1g

4-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1?6-thiane-1,1-dione, 97.0%, 1g

1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide Hydrochloride [Coupling Agent for Peptides Synthesis]>98.0%(T)5g